Cross-cultural adaptation and validation of the self-reporting questionnaire among HIV+ individuals in a rural ART program in southern Uganda

HIV/AIDS - Research and Palliative Care

Volumn 4, Issue , 2012, Pages 51-60

  Nakimuli Mpungu, Etheldreda ^a,b   Mojtabai, Ramin ^a   Alexandre, Pierre K ^a   Katabira, Elly ^b   Musisi, Seggane ^b   Nachega, Jean B ^a,c   Bass, Judith K ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Cross cultural adaptation and validation; Depression; HIV AIDS; Self reporting questionnaire; Uganda

Indexed keywords

ANTIRETROVIRUS AGENT;

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; CONTROLLED STUDY; CROSS CULTURAL ADAPTATION; DEPRESSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PREVALENCE; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; RURAL AREA; SCREENING TEST; SELF REPORTING QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; STRUCTURED INTERVIEW; UGANDA; VALIDATION PROCESS; VALIDITY;

EID: 84860639304     PISSN: None     EISSN: 11791373     Source Type: Journal    
DOI: 10.2147/hiv.s29818     Document Type: Article

References (52)

1. Do NT, Phiri K, Bussmann H, Gaolathe T, Marlink RG, Wester CW. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Res Hum Retroviruses. 2010;26(6): 685-691.
2. Etienne M, Hossain M, Redfield R, Stafford K, Amoroso A. Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries. J Int Assoc Physicians AIDS Care (Chic). 2010;9(2):98-103.
3. Peltzer K, Friend-du Preez N, Ramlagan S, Anderson J. Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2010;10:111.
4. Kagee A, Martin L. Symptoms of depression and anxiety among a sample of South African patients living with HIV. AIDS Care. 2010;22(2):159-165.
5. Kaharuza FM, Bunnell R, Moss S, et al. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 2006; 10(Suppl 4):S105-S111.
6. Poupard M, Ngom Gueye NF, Thiam D, et al. Quality of life and depression among HIV-infected patients receiving efavirenz-or protease inhibitor-based therapy in Senegal. HIV Med. 2007;8(2):92-95.
7. Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K. Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in southwest Ethiopia. BMC Public Health. 2008;8:265.
8. Cohen MH, Fabri M, Cai X, et al. Prevalence and predictors of posttraumatic stress disorder and depression in HIV-infected and at-risk Rwandan women. J Womens Health (Larchmt). 2009;18(11): 1783-1791.
9. Myer L, Seedat S, Stein DJ, Moomal H, Williams DR. The mental health impact of AIDS-related mortality in South Africa: a national study. J Epidemiol Community Health. 2009;63(4): 293-298.
10. Spies G, Kader K, Kidd M, et al. Validity of the K-10 in detecting DSM-IV-defined depression and anxiety disorders among HIV-infected individuals. AIDS Care. 2009;21(9):1163-1168.
11. Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDS. 2008;22(2):147-158.
12. Adewuya AO, Afolabi MO, Ola BA, et al. Relationship between depression and quality of life in persons with HIV infection in Nigeria. Int J Psychiatry Med. 2008;38(1):43-51.
13. Marwick KF, Kaaya SF. Prevalence of depression and anxiety disorders in HIV-positive outpatients in rural Tanzania. AIDS Care. 2010;22(4):415-419.
14. Olley BO, Seedat S, Stein DJ. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study. J Psychosom Res. 2006;61(4):479-484.
15. Lawler K, Mosepele M, Seloilwe E, et al. Depression among HIVpositive individuals in Botswana: a behavioral surveillance. AIDS Behav. 2009;15(1):204-208.
16. Nakimuli-Mpungu E, Mutamba B, Othengo M, Musisi S. Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study. Afr Health Sci. 2009;9 Suppl 1:S2-S7.
17. Weidle PJ, Wamai N, Solberg P, et al. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet. 2006;368(9547):1587-1594.
18. Nakasujja N, Skolasky RL, Musisi S, et al. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry. 2010;10(1):44.
19. Kendrick T, Peveler R. Guidelines for the management of depression: NICE work? Br J Psychiatry. 2010;197:345-347.
20. Maj M, Satz P, Janssen R, et al. WHO neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry. 1994;51(1):51-61.
21. Shacham E, Reece M, Ong'or WO, Omollo O, Basta TB. A cross-cultural comparison of psychological distress among individuals living with HIV in Atlanta, Georgia, and Eldoret, Kenya. J Int Assoc Physicians AIDS Care (Chic). 2010;9(3):162-169.
22. Musisi S, Kinyanda E. Emotional and behavioural disorders in HIV seropositive adolescents in urban Uganda. East Afr Med J. 2009;86(1):16-24.
23. Muhwezi WW, Okello ES, Neema S, Musisi S. Caregivers' experiences with major depression concealed by physical illness in patients recruited from central Ugandan primary health care centers. Qual Health Res. 2008;18(8):1096-1114.
24. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180-202.
25. Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181-187.
26. Bolton P, Bass J, Neugebauer R, et al. Group interpersonal psychotherapy for depression in rural Uganda: a randomized controlled trial. JAMA. 2003;289(23):3117-3124.
27. Verdeli H, Clougherty K, Bolton P, et al. Adapting group interpersonal psychotherapy for a developing country: experience in rural Uganda. World Psychiatry. 2003;2(2):114-120.
28. World Health Organization. A User's Guide to the Self Reporting Questionnaire (SRQ). Geneva: WHO; 1994.
29. Araya R, Wynn R, Lewis G. Comparison of two self administered psychiatric questionnaires (GHQ-12 and SRQ-20) in primary care in Chile. Soc Psychiatry Psychiatr Epidemiol. 1992;27(4):168-173.
30. Giang KB, Allebeck P, Kullgren G, Tuan NV. The Vietnamese version of the Self Reporting Questionnaire 20 (SRQ-20) in detecting mental disorders in rural Vietnam: a validation study. Int J Soc Psychiatry. 2006;52(2):175-184.
31. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33, quiz 34-57.
32. Flaherty JA, Gaviria FM, Pathak D, et al. Developing instruments for cross-cultural psychiatric research. J Nerv Ment Dis. 1988;176: 257-263.
33. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
34. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: Wiley; 1986.
35. Zwick W, Velicer W. Comparison of five rules for determining the number of components to retain. Psychol Bull. 1986;99:432-442.
36. Okello ES, Ekblad S. Lay concepts of depression among the Baganda of Uganda: a pilot study. Transcult Psychiatry. 2006;43(2):287-313.
37. Bass JK, Bolton PA, Murray LK. Do not forget culture when studying mental health. Lancet. 2007;370(9591):918-919.
38. Canino G, Bravo M. The translation and adaptation of diagnostic instruments for cross-cultural use. In: Shaffer D, Lucas CP, Richters JE, editors. Diagnostic Assessment in Child and Adolescent Psychopathology. New York: Guilford Press; 1999.
39. Bass JK, Ryder RW, Lammers MC, Mukaba TN, Bolton PA. Post-partum depression in Kinshasa, Democratic Republic of Congo: validation of a concept using a mixed-methods cross-cultural approach. Trop Med Int Health. 2008;13(12):1534-1542.
40. Bolton P, Wilk CM, Ndogoni L. Assessment of depression prevalence in rural Uganda using symptom and function criteria. Soc Psychiatry Psychiatr Epidemiol. 2004;39(6):442-447.
41. Betancourt TS, Bass J, Borisova I, et al. Assessing local instrument reliability and validity: a field-based example from northern Uganda. Soc Psychiatry Psychiatr Epidemiol. 2009;44(8):685-692.
42. Chen S, Zhao G, Li L, Wang Y, Chiu H, Caine E. Psychometric properties of the Chinese version of the Self-Reporting Questionnaire 20 (SRQ-20) in community settings. Int J Soc Psychiatry. 2009; 55(6):538-547.
43. Al-Subaie AS, Mohammed K, Al-Malik T. The Arabic self-reporting questionnaire (SRQ) as a psychiatric screening instrument in medical patients. Ann Saudi Med. 1998;18(4):308-310.
44. Harpham T, Reichenheim M, Oser R, et al. Measuring mental health in a cost-effective manner. Health Policy Plan. 2003;18(3):344-349.
45. Sartorius N, Janca A. Psychiatric assessment instruments developed by the World Health Organization. Soc Psychiatry Psychiatr Epidemiol. 1996;31(2):55-69.
46. Nakigudde J, Tugumisirize J, Musisi S. Validation of the SRQ-20 in primary care in Uganda. Proceedings of the First Annual Makerere University Faculty of Medicine Scientific Conference. November 24-25, 2005; Entebbe.
47. Ludermir AB, Lewis G. Investigating the effect of demographic and socioeconomic variables on misclassification by the SRQ-20 compared with a psychiatric interview. Soc Psychiatry Psychiatr Epidemiol. 2005;40(1):36-41.
48. Okello ES, Neema S. Explanatory models and help-seeking behavior: pathways to psychiatric care among patients admitted for depression in Mulago hospital, Kampala, Uganda. Qual Health Res. 2007; 17(1):14-25.
49. Leserman J, Pence BW, Whetten K, et al. Relation of lifetime trauma and depressive symptoms to mortality in HIV. Am J Psychiatry. 2007; 164(11):1707-1713.
50. Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;44(2):159-166.
51. Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr. 2006;42(3):298-306.
52. Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384-390.